The Trump administration’s push to revive the controversial “most favored nation” (MFN) pricing policy -- alongside ongoing uncertainty around tariffs and Medicare drug price negotiations -- is ...

With two months to go until Election Day, and early voting kicking off later this month in half a dozen states, Democrats are increasingly optimistic they can recapture congressional majorities. With ...

The best AI tools for job interview preparation include Exponent Practice, AceRound AI, Yoodli, MyInterviewAI, Interviewing.io, Big Interview, Huru AI, and Ophy AI. They offer mock interviews, ...

If you take a patented, brand-name medication — a cancer biologic, an autoimmune drug, a specialty injection — the supply chain behind that drug is about to be permanently restructured, starting at 12 ...

President Donald Trump is threatening to impose a 100% tariff on imported generic medications, which could raise costs for Americans unless drugmakers can move production to the U.S. by August 2028.

Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for ...

President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.

A multiyear “tariff cliff” sets 0% through July 2028, then 100% for one year and 200% thereafter, explicitly tying penalties to failure to establish US manufacturing capacity. Sparse implementation ...

The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves patented uses out of its label. FDA can navigate Hikma’s aftermath without ...

Share on Pinterest Federal regulators have agreed to review a Swiss pharmaceutical company’s applications for two cheaper generic versions of Zepbound and Mounjaro. MK Photo/Alamy Stock Photo Federal ...